Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
We have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 &a...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/24/6/1002 |
id |
doaj-b06a560c519246fabd49a80c32aafcd6 |
---|---|
record_format |
Article |
spelling |
doaj-b06a560c519246fabd49a80c32aafcd62020-11-24T22:19:29ZengMDPI AGMolecules1420-30492019-03-01246100210.3390/molecules24061002molecules24061002Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking StudyNoor Barak Almandil0Muhammad Taha1Rai Khalid Farooq2Amani Alhibshi3Mohamed Ibrahim4El Hassane Anouar5Mohammed Gollapalli6Fazal Rahim7Muhammad Nawaz8Syed Adnan Ali Shah9Qamar Uddin Ahmed10Zainul Amiruddin Zakaria11Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Neuroscience Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Neuroscience Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Chemistry, College of Sciences and Humanities, Prince Sattam bin Abdulaziz University, P.O. Box 83, Al-Kharij 11942, Saudi ArabiaCollege of Computer Science & Information Technology (CCSIT) Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Chemistry, Hazara University, Mansehra 21300, Khyber Pakhtunkhwa, PakistanDepartment of Nano-Medicine Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaFaculty of Pharmacy, Universiti Teknologi MARA Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D.E., MalaysiaDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, 25200 Kuantan Pahang DM, MalaysiaDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, MalaysiaWe have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies.http://www.mdpi.com/1420-3049/24/6/1002quinoxaline analogssynthesisthymidine phosphorylase inhibitionmolecular docking |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Noor Barak Almandil Muhammad Taha Rai Khalid Farooq Amani Alhibshi Mohamed Ibrahim El Hassane Anouar Mohammed Gollapalli Fazal Rahim Muhammad Nawaz Syed Adnan Ali Shah Qamar Uddin Ahmed Zainul Amiruddin Zakaria |
spellingShingle |
Noor Barak Almandil Muhammad Taha Rai Khalid Farooq Amani Alhibshi Mohamed Ibrahim El Hassane Anouar Mohammed Gollapalli Fazal Rahim Muhammad Nawaz Syed Adnan Ali Shah Qamar Uddin Ahmed Zainul Amiruddin Zakaria Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study Molecules quinoxaline analogs synthesis thymidine phosphorylase inhibition molecular docking |
author_facet |
Noor Barak Almandil Muhammad Taha Rai Khalid Farooq Amani Alhibshi Mohamed Ibrahim El Hassane Anouar Mohammed Gollapalli Fazal Rahim Muhammad Nawaz Syed Adnan Ali Shah Qamar Uddin Ahmed Zainul Amiruddin Zakaria |
author_sort |
Noor Barak Almandil |
title |
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study |
title_short |
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study |
title_full |
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study |
title_fullStr |
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study |
title_full_unstemmed |
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study |
title_sort |
synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2019-03-01 |
description |
We have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies. |
topic |
quinoxaline analogs synthesis thymidine phosphorylase inhibition molecular docking |
url |
http://www.mdpi.com/1420-3049/24/6/1002 |
work_keys_str_mv |
AT noorbarakalmandil synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT muhammadtaha synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT raikhalidfarooq synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT amanialhibshi synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT mohamedibrahim synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT elhassaneanouar synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT mohammedgollapalli synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT fazalrahim synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT muhammadnawaz synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT syedadnanalishah synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT qamaruddinahmed synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy AT zainulamiruddinzakaria synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy |
_version_ |
1725778914060533760 |